...
首页> 外文期刊>Medicine. >Genetic variants in cardiac calcification in Northern Sweden
【24h】

Genetic variants in cardiac calcification in Northern Sweden

机译:瑞典北部心脏钙化的遗传变异

获取原文

摘要

Extensive coronary calcification without significant stenosis, described as calcific coronary artery disease (CCAD) may cause abnormal myocardial perfusion and hence generalized ischemia. There is a discrepancy in the expression pattern of CCAD compared to the well-known atherosclerotic disease which raises questions about the exact pathophysiology of coronary calcification and whether there is a genetic etiology for it. In this pilot study we studied 3 candidate genes, ectonucleotide pyrophosphatase/phosphodiesterase ( ENPP1 ), ATP Binding Cassette Subfamily C Member 6 ( ABCC6 ), and 5’-Nucleotidase Ecto ( NT5E ) involved in pyrophosphate (PPsub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub) and inorganic phosphate (Psub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub) metabolism, which may predispose to coronary arterial or valvular calcification. We studied 70 patients with calcific cardiac disease; 65 with CCAD (age 43–83 years) and 5 with calcific aortic valve disease (CAVD) (age 76–82 years). Five DNA variants potentially affecting protein function were found in 6 patients. One variant is a known disease-causing mutation in the ABCC6 gene . Our findings support that disturbances in the PPsub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub and Psub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub metabolism might influence the development of CCAD and CAVD. However, segregation in the families must first be performed to ascertain any damaging effect of these variants we have found. We report 4 new genetic variants potentially related to coronary calcification, through the disturbed Psub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub and PPsub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub metabolism. The search for direct causative genetic variants in coronary artery and aortic valve calcification must be broadened with other genes particularly those involved with Psub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub and PPsub xmlns:mrws="http://webservices.ovid.com/mrws/1.0"i/sub metabolism.
机译:没有明显狭窄的广泛冠状动脉钙化,被称为钙化冠状动脉疾病(CC​​AD)可能会导致异常的心肌灌注,从而导致局部缺血。与众所周知的动脉粥样硬化疾病相比,CCAD的表达方式存在差异,这引发了有关冠状动脉钙化的确切病理生理以及是否存在遗传病因的疑问。在这项初步研究中,我们研究了3个候选基因,即外核苷酸焦磷酸酶/磷酸二酯酶(ENPP1),ATP结合盒式亚家族C成员6(ABCC6)和5'-核苷酸酶Ecto(NT5E)参与焦磷酸(PP i )和无机磷酸盐(P i < / sub>)新陈代谢,可能导致冠状动脉或瓣膜钙化。我们研究了70例钙化性心脏病患者。 CCAD为65岁(43-83岁),钙化主动脉瓣疾病(CAVD)为5岁(76-82岁)。在6名患者中发现了5个可能影响蛋白质功能的DNA变异体。一种变体是ABCC6基因中已知的致病突变。我们的发现支持PP i 和P i 代谢可能会影响CCAD和CAVD的发展。但是,必须首先进行家庭隔离,以确定我们发现的这些变体的任何破坏作用。我们通过受干扰的P i 和PP i 新陈代谢。必须使用其他基因,尤其是与P i相关的基因,扩大在冠状动脉和主动脉瓣钙化中直接致病性遗传变异的搜索范围。 sub>和PP i 代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号